Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

Coronavirus

Many Iowans plan to wait on taking coronavirus vaccine: poll

45% of Iowans won't get the COVID-19 vaccine once it becomes available

By Jonathan Garber Fox News
Published
close
The Vaccine Race Quickens as the Virus Surges Across Europe Video

The Vaccine Race Quickens as the Virus Surges Across Europe

Paul Gigot interviews Dr. Martin Makary of Johns Hopkins University.

Iowans will take a wait-and-see approach to a COVID-19 vaccine, according to a new poll.

Forty-five percent of adult Iowans say they will wait until others have taken a vaccine before getting the shot themselves, according to a new Des Moines Register/Mediacom Iowa Poll. Another 28% plan to be vaccinated as soon as possible and 21% say they won’t take it at all.

Just 6% of Democrats don’t plan to take a vaccine once it becomes available, compared with 28% of Republicans and 20% of independents.

DEM CHALLENGER TO IOWA SEN. ERNST SHIFTS LANGUAGE ON PACKING SUPREME COURT

The poll, which surveyed 803 Iowans between Sept. 14 and Sept. 17, had a margin of error of plus or minus 3.5 points.

Iowans' opinions regarding a vaccine were mostly in line with a national USA Today Poll published earlier this month.

While skepticism remains about the effectiveness of a vaccine, a speedy discovery may help the U.S., and the rest of the world, fend off a second wave of the virus that many experts said could come as soon as the fall.

Vaccines from AstraZeneca plc, Johnson & Johnson, Moderna Inc., Novavax Inc. and Pfizer Inc. and BioNTech SA are currently in Phase 3 trials.

WHITE HOUSE TELLS IOWA UNIVERSITIES TO RAMP UP CORONAVIRUS TESTING

The results from Pfizer and BioNTech’s late-stage trial are expected sometime in October. Johnson & Johnson and Moderna, meanwhile, said the effectiveness of their experimental vaccines may be known in October, but will likely be available a little later.

President Trump in May launched Operation Warp Speed, which aims to produce and deliver 300 million doses of a safe and effective COVID-19 vaccine by January 2021.

CLICK HERE TO GET THE FOX NEWS APP

Nearly $10 billion of funding has been deployed through the program to speed up the development, production and distribution of vaccines, therapeutics and diagnostics.